Jim Simons’s BioNTech BNTX Stock Holding History

Jim Simons’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-445,019	Closed	-$48M	–	3683
2023 Q2	$48M	Sell	445,019 -64,572	-13%	-$7.26M	0.07%	328
2023 Q1	$63.5M	Buy	509,591 +178,107	+54%	+$24.5M	0.08%	284
2022 Q4	$49.8M	Buy	+331,484	New	+$51M	0.07%	339
2022 Q3	–	Sell	-238,619	Closed	-$35.6M	–	4038
2022 Q2	$35.6M	Sell	238,619 -11,800	-5%	-$1.8M	0.04%	471
2022 Q1	$42.7M	Buy	+250,419	New	+$42.1M	0.05%	395
2021 Q3	–	Sell	-328,614	Closed	-$73.6M	–	3484
2021 Q2	$73.6M	Buy	+328,614	New	+$62M	0.09%	227

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Jim Simons's BNTX Position: Q3 2023 in Review

Jim Simons sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 445,019 shares — an estimated $48M sold.

Jim Simons first reported a position in BNTX in Q2 2021 and held it in 6 quarters. The position peaked at $73.6M in Q2 2021. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

Jim Simons reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
Jim Simons sold 445,019 BioNTech shares in Q3 2023, an estimated $48M.
Jim Simons first reported a position in BioNTech in Q2 2021 and held it in 6 quarters.
Jim Simons's BioNTech position peaked at $73.6M in Q2 2021.
252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.